SBI was among the participants in the financial management tool developer's seriies B round, which will fund product development and US expansion.

The rocket launcher spinout of TUM has received $90.8m in a UVC Partners-backed round as it prepares for a first commercial launch in 2022.

University of Oxford joined Oxford Sciences Innovation to back neuromuscular disease therapy spinout PepGen, which will move its base to the US.

Novo returned to reinvest in the neuromuscular disorder therapy developer in a round that will fund the progress of its lead candidate through a phase 1 clinical trial.

The digital medicine provider has closed a round led by SoftBank Vision Fund 2 that also featured Novartis, taking its total funding to at least $214m.

The database technology provider formerly known as MemSQL increased its overall financing to $238m in a round featuring GV, REV and Dell Technologies Capital.

The rocket launcher developer has received $90.8m in an Airbus Ventures-backed round as it prepares for a first commercial launch in 2022.

Alexandria Venture Investments has helped RNA drug developer Remix Therapeutics launch with seed and series A funding.

Citi Ventures participated in the first non-crowdfunded equity round to be disclosed by the kids' finance management app developer.

Amgen is a shareholder of Vigil Neuroscience, which is developing microglia-based treatments for neurodegenerative diseases.